Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Dosing of Pomalidomide in RRMM
NCT05555329Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2022
- Primary completion
- Feb 2024
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 4 trial of pomalidomide in multiple myeloma (MM), sponsored by Amsterdam University Medical Center. Started Dec 2022; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05555329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05555329.